TTF1 antibody
Principal name
TTF1 antibody
Alternative names for TTF1 antibody
TTF-1, TTF-I, Transcription termination factor 1, RNA polymerase I termination factor
Ncbi ID
NP_001192225.1, NM_009442, NM_007344, AAI67784.1, NP_033468.2
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB), Flow Cytometry (F)
Background of TTF1 antibody
- Kit Component:
- - KN318432G1, Ttf1 gRNA vector 1 in pCas-Guide vector
- KN318432G2, Ttf1 gRNA vector 2 in pCas-Guide vector
- KN318432D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Mouse Heart; WB Suggested Anti-Ttf1 Antibody Titration: 0.2-1 ug/ml. Positive Control: Mouse Heart; Ttf1 antibody - N-terminal region (ARP36997_P050) in Mouse Heart cells using Western Blot
Mouse NIH-3T3; . Lanes: 30ug NIH3T3 cell lysate. Primary Antibody Dilution: 1:1000. Secondary Antibody: Anti-rabbit HRP. Secondary Antibody Dilution: 1: 5000. Gene Name: Ttf1. Submitted by: Thomas Moss.; Ttf1 antibody - N-terminal region (ARP36997_P050) in Mouse NIH-3T3 cells using Western Blot
Human Fetal liver; WB Suggested Anti-TTF1 Antibody. . Titration: 1.0 ug/ml. . Positive Control: Fetal Liver; TTF1 antibody - middle region (ARP61242_P050) in Human Fetal liver cells using Western Blot
Human thyroid stained with anti-TTF-1 Antibody Cat.-No AM33210PU (Clone SP141)
Flow Cytometric analysis of anti-TTF-1 Antibody Cat.-No AM33210PU (Clone SP141) in HeLa (green) compare to negative control of rabbit IgG (blue).
Immunohistochemical analysis of TTF1 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugad compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of TTF1 expression in HEK293T (A); Raw264.7 (B); H9C2 (C) whole cell lysates.
WB Suggested Anti-Ttf1 Antibody Titration: 0.2-1 ug/ml; Positive Control: Mouse Heart
Lanes: ; 30ug NIH3T3 cell lysate; Primary Antibody Dilution: ; 1:1000; Secondary Antibody: ; Anti-rabbit HRP; Secondary Antibody Dilution: ; 1: 5000; Gene Name: ; Ttf1; Submitted by: ; Thomas Moss;
WB Suggested Anti-TTF1 Antibody; Titration: 1.0 ug/ml; Positive Control: Fetal Liver
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA341824 | TTF1 antibody |
||||||
| Rabbit Polyclonal Anti-Ttf1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Ms, Rt | WB |
0.1 ml /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA343134 | TTF1 antibody |
||||||
| Rabbit Polyclonal Anti-TTF1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | WB |
0.1 ml /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC219171L2V | Lenti ORF particles, TTF1 (mGFP-tagged) - Human transcription termination factor, RNA polymerase I (TTF1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€2,010.00
|
|
| OriGene Technologies, Inc. | ||
| RC219171L1V | Lenti ORF particles, TTF1 (Myc-DDK tagged) - Human transcription termination factor, RNA polymerase I (TTF1), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,800.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210876L2V | Lenti ORF particles, Ttf1 (GFP-tagged) - Mouse transcription termination factor, RNA polymerase I (Ttf1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,690.00
|
|
| OriGene Technologies, Inc. | ||
| MR210876L1V | Lenti ORF particles, Ttf1 (Myc-DDK-tagged) - Mouse transcription termination factor, RNA polymerase I (Ttf1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,520.00
|
|
| OriGene Technologies, Inc. | ||
